SUMMARY: From the prices of medications to the choice of doctors and treatments the idea that people are “consumers of healthcare” is a canard. The fact that we don’t have control is one reason why Gallup reported that so many people are unsatisfied with the state of healthcare in the U.S.Continue reading
- Seventy-two percent of Americans believe the U.S.
healthcare systemis “in a state of crisis” or “has major problems,” almost the same percentage (71%) who felt that way a few months before the Affordable Care Act was passed seven years ago. (Source: Gallup).
- The combined percentages saying the nation’s system
isin crisis or is having major problems has stayed in a seven-percentage-point range (from 67% to 74%) over the past 10 years.
- The global insulin market is dominated by three companies: Eli Lilly, the French company Sanofi and the Danish firm Novo Nordisk.
- In the past decade alone, U.S. insulin list prices have tripled, according to an analysis of data from IBM Watson Health
- According to IBM Watson Health data, Sanofi’s popular insulin brand Lantus was $35 a vial when it was introduced in 2001; it’s now $270. Novo Nordisk’s Novolog was priced at $40 in 2001, and as of July 2018, it’s $289.
- Stories of people rationing insulin and dying as a result continue to appear in the media.
- Billions of dollars are pouring into digital health.
- However, Americans aren’t getting any healthier.
Millennialsare so overweight that they could be the most obese generation in history.
lifeexpectancy has fallen forthe last three years, while it rises all around the world.
- Lilly has decided to inform patients about the list price for Trulicity on their website.
- The information may add to patient anger and raise more questions.
- What makes a drug worth $8000 a year and who get’s the money?
- According to JAMA “annual health care
marketingsurged from $17.7 billion in 1997 to at least $29.9 billion in 2016, driven by a rapid spike in spending on direct-to-consumer (DTC) advertisements for prescription drugs. Over this period, DTC spending climbed from $2.1 billion to $9.6 billion.
- The most rapid increase was in direct-to-consumer (DTC) advertising, which increased from $2.1 billion (11.9%) of total spending in 1997 to $9.6 billion (32.0%) of total spending in 2016. DTC prescription drug advertising increased from $1.3 billion (79 000 ads) to $6 billion (4.6 million ads [including 663 000 TV commercials]), with a shift toward advertising high-cost
biologicsand cancer immunotherapies.
- Even if all prescription drugs were free healthcare costs would still be increasing.
- Top Celgene executives will collect 2.5X their salary and bonus in cash if they leave after the deal with BMS closes.
- A new severance agreement was formalized days ahead of the buyout press releases.
- CEO Mark Alles will get three times his salary when he leaves.